Osstem Implant, whose stock trading was suspended due to an employee embezzlement of 200 billion won, will remain listed and stock trading will resume tomorrow (28th).
The Korea Exchange announced that it has decided to keep Osstem Implant listed as a result of deliberation by the Corporate Review Committee.
The exchange said, "The fact that Osstem Implant improved its governance structure by appointing a majority of outside directors and establishing an audit committee through a general shareholders' meeting on the 31st of last month, and verified the adequacy of operating the internal accounting management system for money management through a third-party specialized agency. We have decided to keep the listing,” he explained.
On January 3rd, Osstem Implant announced that it had sued Mr. Lee, a money management employee, on charges of embezzlement on the job.
The amount of embezzlement is 221.5 billion won.
(Photo = Yonhap News)